Earlier this week the Department of Health and Human Services (“HHS”) published its long awaited notice of proposed rulemaking regarding the registration of clinical trials. The most significant change that would result from implementation of the proposed rule, and the one getting the most press, is the new requirement that results data be
More Posts
Five Issues to Consider While Reviewing the Clinical Trial Registration Proposed Rule
FDA’s Second Guidance on the Drug Supply Chain Security Act Misses the Mark
FDA’s Second Guidance on the Drug Supply Chain Security Act Misses the Mark
Three Takeaways from the Advances in Clinical Technology Conference
Three Takeaways from the Advances in Clinical Technology Conference
FDA Jurisdictional Determinations Should Not Be a Riddle, Wrapped in a Mystery, Inside an Enigma
FDA Jurisdictional Determinations Should Not Be a Riddle, Wrapped in a Mystery, Inside an Enigma
Contrary to Misconceptions, a Final Guidance is Not a Final Rule
Contrary to Misconceptions, a Final Guidance is Not a Final Rule
Subscribe: Subscribe via RSS
Blogs
Firm/Org